278 related articles for article (PubMed ID: 9589232)
1. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM.
Perry IJ; Wannamethee SG; Shaper AG
Diabetes Care; 1998 May; 21(5):732-7. PubMed ID: 9589232
[TBL] [Abstract][Full Text] [Related]
2. Serum true insulin concentration and the risk of clinical non-insulin dependent diabetes during long-term follow-up.
Perry IJ; Wannamethee SG; Shaper AG; Alberti KG
Int J Epidemiol; 1999 Aug; 28(4):735-41. PubMed ID: 10480704
[TBL] [Abstract][Full Text] [Related]
3. Γ-glutamyltransferase, hepatic enzymes, and risk of incident heart failure in older men.
Wannamethee SG; Whincup PH; Shaper AG; Lennon L; Sattar N
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):830-5. PubMed ID: 22223732
[TBL] [Abstract][Full Text] [Related]
4. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.
Nannipieri M; Gonzales C; Baldi S; Posadas R; Williams K; Haffner SM; Stern MP; Ferrannini E;
Diabetes Care; 2005 Jul; 28(7):1757-62. PubMed ID: 15983331
[TBL] [Abstract][Full Text] [Related]
5. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
[TBL] [Abstract][Full Text] [Related]
6. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.
André P; Balkau B; Born C; Charles MA; Eschwège E;
Diabetologia; 2006 Nov; 49(11):2599-603. PubMed ID: 16969645
[TBL] [Abstract][Full Text] [Related]
7. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population.
Meisinger C; Löwel H; Heier M; Schneider A; Thorand B;
J Intern Med; 2005 Dec; 258(6):527-35. PubMed ID: 16313476
[TBL] [Abstract][Full Text] [Related]
8. Liver enzymes and incident diabetes in China: a prospective analysis of 10 764 participants in the Guangzhou Biobank Cohort Study.
Xu L; Jiang CQ; Schooling CM; Zhang WS; Cheng KK; Lam TH
J Epidemiol Community Health; 2015 Nov; 69(11):1040-4. PubMed ID: 26139641
[TBL] [Abstract][Full Text] [Related]
9. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes.
Wannamethee G; Ebrahim S; Shaper AG
Am J Epidemiol; 1995 Oct; 142(7):699-708. PubMed ID: 7572939
[TBL] [Abstract][Full Text] [Related]
10. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.
Wannamethee SG; Shaper AG; Lennon L; Whincup PH
Diabetes Care; 2005 Dec; 28(12):2913-8. PubMed ID: 16306554
[TBL] [Abstract][Full Text] [Related]
11. Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men.
Nakanishi N; Nishina K; Li W; Sato M; Suzuki K; Tatara K
J Intern Med; 2003 Sep; 254(3):287-95. PubMed ID: 12930239
[TBL] [Abstract][Full Text] [Related]
12. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.
Nakanishi N; Suzuki K; Tatara K
Diabetes Care; 2004 Jun; 27(6):1427-32. PubMed ID: 15161799
[TBL] [Abstract][Full Text] [Related]
13. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Kim CH; Park JY; Lee KU; Kim JH; Kim HK
Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
[TBL] [Abstract][Full Text] [Related]
14. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.
Vozarova B; Stefan N; Lindsay RS; Saremi A; Pratley RE; Bogardus C; Tataranni PA
Diabetes; 2002 Jun; 51(6):1889-95. PubMed ID: 12031978
[TBL] [Abstract][Full Text] [Related]
15. Hematocrit and risk of NIDDM.
Wannamethee SG; Perry IJ; Shaper AG
Diabetes; 1996 May; 45(5):576-9. PubMed ID: 8621006
[TBL] [Abstract][Full Text] [Related]
16. Association between elevated serum hepatic enzyme activity and total body fat in obese humans.
Choi JW
Ann Clin Lab Sci; 2003; 33(3):257-64. PubMed ID: 12956439
[TBL] [Abstract][Full Text] [Related]
17. Serum γ-glutamyltransferase as an independent predictor for incident type 2 diabetes in middle-aged and older adults: Findings from the KoGES over 12 years of follow-up.
Lee JH; Lee HS; Lee YJ
Nutr Metab Cardiovasc Dis; 2020 Aug; 30(9):1484-1491. PubMed ID: 32600956
[TBL] [Abstract][Full Text] [Related]
18. Gamma-glutamyltransferase and risk of prostate cancer: Findings from the KIHD prospective cohort study.
Kunutsor SK; Laukkanen JA
Int J Cancer; 2017 Feb; 140(4):818-824. PubMed ID: 27861848
[TBL] [Abstract][Full Text] [Related]
19. Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: the Kansai Healthcare Study.
Sato KK; Hayashi T; Nakamura Y; Harita N; Yoneda T; Endo G; Kambe H
Diabetes Care; 2008 Jun; 31(6):1230-6. PubMed ID: 18316395
[TBL] [Abstract][Full Text] [Related]
20. gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women.
Lee DH; Silventoinen K; Jacobs DR; Jousilahti P; Tuomileto J
J Clin Endocrinol Metab; 2004 Nov; 89(11):5410-4. PubMed ID: 15531490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
